🇺🇸 FDA
Pipeline program

PROLEUKIN 18 millions U.I., poudre pour solution injectable, CHLORURE DE SODIUM 0,9 % B. BRAUN, solution injectable en ampoule

D20-P012

Phase 2 small_molecule active

Quick answer

PROLEUKIN 18 millions U.I., poudre pour solution injectable, CHLORURE DE SODIUM 0,9 % B. BRAUN, solution injectable en ampoule for Alzheimer Disease is a Phase 2 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Alzheimer Disease
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials